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Abstract
Background: The prenatal diagnosis of subjects with complete uniparental isodisomy of chromosome 4 (iUPD4)
has rarely been reported and poses a great challenge for genetic counseling. In this study, a prenatal case with a
high (1 in 58) risk of Down syndrome was diagnosed with iUPD4 by combined chromosomal microarray analysis
(CMA), whole exome sequencing (WES) and ultrasound morphology scan.
Results: By CMA, a pathogenic copy number variant was not detected; however, a complete maternal iUPD4 was
identified in this fetus after analyzing the parental genotype results. To detect potentially autosomal recessive
variants, WES was performed. Two missense and two frameshift variants were identified but were predicted with
uncertain significance; none of the mutations were definitively associated with congenital abnormality or inherited
disease. In addition, a detailed ultrasound morphology scan did not identify any structural abnormalities, facial
dysmorphisms or intrauterine growth restriction. The family history was unremarkable. The couple was counseled
with the prenatal diagnostic results, and they opted to give birth to the child. No phenotypic abnormalities were
observed in this child after the first year of life.
Conclusion: This study provides further evidence that iUPD4 can result in a healthy live birth and demonstrates
that the combined use of CMA, WES and ultrasound technology provides additional information for the prenatal
diagnosis and clinical management of rare UPD events.
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Ultrasound
Background
Uniparental disomy (UPD) is defined as an inheritance
of both homologous chromosomes from a single parent
without contribution from the other parent [1]. Based
on different mechanisms and different origins of the di-
somic chromosome, UPD can present as maternal UPD,
paternal UPD, uniparental heterodisomy (hUPD, two dif-
ferent chromosomal homologs inherited from the same
parent), uniparental isodisomy (iUPD, two identical cop-
ies of a single homolog), whole-chromosome UPD and
segmental UPD [2–4].
The incidence of UPD is estimated to be approxi-
mately 1:3500 live births [5]. The pathogenesis of UPD is
always associated with imprinting disorders or the
unmasking of homozygous mutations in iUPD, which
can trigger autosomal recessive diseases [6–8]. To date,
the clinically relevant UPD phenotypes that have been
definitively associated with imprinting disorders are lim-
ited to regions of 6q24, 7p11.2-p12, 7p32.2, 11p15.5,
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14q32.2, 15q11-q13 and 20q13.3 [9–13]. Therefore, gen-
etic counseling is difficult, especially counseling for pre-
natal diagnoses and for those exhibiting UPD on
chromosomal regions that are not listed above. In
addition, although more than 100 imprinted genes that
have been identified in the human genome (http://
www.geneimprint.com/), the understanding of how most
of the imprinted genes function is limited. Tissue-
specific imprinting and controversial reports of some
imprinted genes adds to the complexity for genetic
counseling [14–16]. Furthermore, merely relying on
ultrasonography data for prenatal genetic counseling
makes it challenging to precisely predict which homozy-
gous variations will “activate” recessive mutation events
or trigger autosomal recessive disorders in a fetus with-
out obvious dysmorphisms.
Although more than 2,800 UPD cases have been re-
ported in the literature (http://upd-tl.com/upd.html), a
case of complete maternal iUPD of chromosome 4 is
very rare, and a prenatal subject with UPD4 has only
been reported once. Currently, there is only one re-
ported case of prenatal hUPD4 [17], three postnatal re-
ported cases of complete maternal iUPD4 [18–20] and
fewer than 10 postnatal reported cases of segmental ma-
ternal iUPD or mixed hUPD and iUPD of chromosome
4 [21–23]. Among these reported cases, most of the clin-
ical phenotypes presented were due to the homozygosity
of a recessive mutation rather than aberrant imprinting,
suggesting that important maternally imprinted genes
are not located on chromosome 4.
Chromosomal microarray analysis (CMA) has been
used for the prenatal diagnosis of fetuses that present
with ultrasound anomalies, and single-nucleotide
polymorphism (SNP)-based CMA has further facili-
tated the detection of iUPD or identical by descent
(IBD) segments, as well as copy number variations
[24–26]. Whole exome sequencing (WES) is a power-
ful tool to search for potential pathogenic variants lo-
cated in an iUPD region [27]. In this study, a
complete maternal iUPD of chromosome 4 was iden-
tified using a SNP-based CMA from a fetal sample,
and subsequently WES was used to identify potential
pathogenic variants. None of the sequence variants
that were identified using WES were associated with
congenital abnormality or inherited disease, and no
structural abnormalities, facial dysmorphisms or intra-
uterine growth restriction (IUGR) was observed in
this fetus using detailed ultrasound scanning. The
couple was counseled with the prenatal diagnostic re-
sults and was additionally informed that an imprint-
ing effect associated with iUPD4 cannot be excluded.
The couple opted to give birth to the child. A healthy
boy was born by vaginal delivery at 40 weeks with a
birth weight of 2.70 kg, length of 49 cm, head
circumference of 33 cm and Apgar scores of 10 each
at 1, 5 and 10 min post-delivery.
Results
Timeframe of gestational weeks for different prenatal
analyses
A brief outline of the timeframe of gestational weeks for
different prenatal diagnoses is listed in Additional file 1:
Table S1.
Identifying CNVs and UPD events with SNP-based CMA
Karyotype testing of the fetal amniotic fluid sample re-
vealed a normal result (46,XY) (Fig. 1). For CNV ana-
lysis, only a single deletion and a single duplication were
identified in the fetal DNA sample, three duplications
were found in the mother, and only a single CNV dupli-
cation was observed in the father (Fig. 2, Table 1.). All of
the identified CNVs were evaluated and have previously
been reported as benign in public databases.
Identification of UPD events
Although no pathogenic CNVs were identified in either
the fetus or his parents, the SNP array indicated a
complete iUPD of chromosome 4 in the fetus based on
the absence of heterozygosity (AOH) across the entire
chromosome (Fig. 3a and b). A whole genome view
using the ChAS software program clearly identified a
187-Mb isodisomic UPD in the entire chromosome 4 re-
gion of the fetus but detected no abnormalities in his
parents (Fig. 3c-e). In addition, the software directly in-
dicated that the isodisomic UPD was of maternal origin
(Fig. 4), and this was validated by comparing 13,201
SNPs on chromosome 4 derived from the CMA results
(from rs12511220 at chr4:75174 to rs7686607 at
chr4:190921709) between the fetus and his parents
(Additional file 2).
The Genomic Oligoarray and SNP array evaluation
tool located a total of 1,472 genes on chromosome
4. Among them, 552 were OMIM genes, and 131
genes were disease associated, including 63 auto-
somal recessive genes and 44 autosomal dominant
genes (Additional file 3).
Whole exome sequencing analysis
WES was performed to investigate whether there were
any SNVs or InDels located in the iUPD regions. WES
yielded a total of 47,224,320 mapped reads with 93.62 %
on target. The total assigned amplicon reads were
44,210,426. Average reads per amplicon was 150.4, with
45.66 % of targets having 100X coverage and 89.41 %
having 20X coverage. The variant call format (VCF) files
were submitted to the wANNOVAR web server (http://
wannovar.usc.edu/) for identification and filtering of the
SNVs. We identified 51,235 variants, including 47,363
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single nucleotide variations, 224 multiple nucleotide var-
iations (MNV) and 3,648 InDels. Among these variants,
there were 1,343 homozygous SNVs, 3 homozygous
MNVs and 65 homozygous InDels that were identified
on chromosome 4 (Table 2).
For variant filtering, the variants observed with an al-
lele frequency greater than or equal to 3.0 % of the ge-
nomes in the 1000 genomes project were excluded and
those variants associated with a phenotype variant were
subjected to further analysis. After filtering using
Fig. 1 Karyotype analysis of the fetus. The fetal amniotic fluid sample showed a normal 46,XY karyotype, and no structural abnormalities or small
markers were observed after counting 20 metaphase cells
Fig. 2 Identification of copy number variations. ChAS software indicated a single deletion (red triangle) and a single duplication of CNVs (blue triangle)
in the fetal sample (blue arrow). Three duplicated CNVs were observed in the mother (red arrow), whereas only a single duplicated CNV was observed
in the father (light blue arrow)
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Ingenuity software, 2 frameshift and 2 nonsynonymous
variants located on chromosome 4 were identified
(Table 3). Although these variants were predicted to
have damaging or possibly damaging functions, none of
them were OMIM disease genes, and none of those vari-
ants were definitely associated with congenital abnor-
mality or inherited disease. Therefore, in this study, all
of the four variants were classified as Variants of Uncer-
tain Significance (VOUS).
Confirmation of identified variants
More than 99 % of the SNPs identified in the WES ana-
lysis coincided with the results derived from the CMA
(data not shown). All four VOUS variants were success-
fully validated by Sanger sequencing (Fig. 5).
Ultrasound morphology scans
Because no pathogenic variants were identified in the
fetus carrying iUPD4, a detailed ultrasound screening
was performed to monitor the fetal development. Mal-
formations detectable with ultrasound, structural abnor-
malities, facial dysmorphisms and intrauterine growth
restrictions (IUGRs) were not observed in the fetus
(Fig. 6). In addition, no other clinical phenotype was ob-
served by the pediatrician during a follow-up period up
to the first year after birth with a weight of 9.50 kg
(50th), length of 74.1 cm (50th) and head circumstance
of 45.5 cm (25th).
Discussion
The widespread use of SNP-based CMA technology has
facilitated the detection of UPD events [28]. SNP-based
CMA is a first-tier diagnostic method for the genetic
screening of fetuses with abnormal ultrasound results, as
well as for diagnosing individuals with developmental
disabilities or congenital anomalies [29, 30]. In addition,
SNP-based CMA is efficient at identifying UPDs, IBD
segments and copy number variations. In our recently
published paper [31], we identified one case of IBD and
two cases of UPD with abnormal phenotypes among a
total of 472 prenatal testing samples, suggesting the in-
creased number of reported UPD cases found in pre-
natal testing due to advances in CMA technology should
have come to our attention.
Although clinically relevant UPD phenotypes have
been described for different chromosomes (http://upd-
tl.com/upd.html), UPD observed in prenatal testing, par-
ticularly for rarely reported UPD chromosomes, pose a
great challenge for genetic counseling. For example, a
complete maternal iUPD of chromosome 4 is very rare,
and prenatal observation of this type of UPD has never
been reported except once in which a prenatal subject
exhibited hUPD4. Recently, Palumbo et al. reported a
10-year-old boy carrying a maternal iUPD of chromo-
some 4 who presented with a mild intellectual disability
and a slight speech delay, but without any dysmorphic
features [20], further suggesting that prediction of the
clinical impact of rare UPD can be complicated.
The hUPD4 case reported by Kuchinka et al.[17] com-
menced as a trisomic zygote with nondisjunction during
maternal meiosis. In our case, the complete iUPD of
chromosome 4 was most likely caused by chromosome
segregation errors in meiosisII, however, fertilization of a
normal egg by a nullisomic sperm with subsequent salvage
of a monosomy by postfertilization duplication of the ma-
ternal chromosome 4 might also have resulted in iUPD4.
The pathogenesis of UPD is always determined by sev-
eral imprinted disorders, such as transient neonatal dia-
betes mellitus (paternal UPD 6q24), Beckwith-
Wiedemann syndrome (paternal UPD 11p15.5), Russell-
Silver syndrome (maternal UPD 7p11-12), Temple syn-
drome (maternal UPD 14q32), Wang syndrome (paternal
UPD 14q32), Angelman syndrome (paternal UPD15q11-
q13), Prader-Willi syndrome (maternal UPD15q11-q13)
Table 1 CNVs identified in the iUPD4 case
Subject CNVs region CNV State Type Sizes Genes within CNVs Function
Fetus chr6:254,253-320,842 1 Loss 67Kb DUSP22 Benign
chr14:106,251,069-106,736,227 3 Gain 485Kb KIAA0125 Benign
ADAM6
Father chr14: 106,167,581-106,769,864 3 Gain 602Kb KIAA0125 Benign
ADAM6
LINC00226
Mother chr14:106,167,581-106,766,782 3 Gain 599Kb KIAA0125 Benign
ADAM6
LINC00226
chr5:17,398,797-17,701,556 3 Gain 303Kb / Benign
chr7:89,367,271-90,601,186 3 Gain 314Kb DPY19L2P4 Benign
STEAP1, STEAP2 et al.
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and pseudohypoparathyroidism type IB (paternal UPD
20q13) [32]. However, whether there are any important
imprinted genes clustered in other chromosomes is cur-
rently unclear. In addition, the tissue specific effect of im-
printing, in which some genes are expressed from both
alleles in the blood but show imprinting in a specific tissue
[33–35], further complicate the functional interpretation
of UPDs which involves those imprinted genes.
Unmasking of pathogenic autosomal recessive variants
in uniparental isodisomy events is another mechanism
for the clinical impact of UPD. In the reported maternal
UPD4 cases, the diverse clinical impact of UPD4 is most
Fig. 3 Complete maternal uniparental isodisomy of chromosome 4. a ChAS revealed a complete iUPD of chromosome 4 in the fetus (blue line)
by showing an absence of heterozygosity (AOH) across the entire chromosome (purple rectangle, blue arrow). The results of an AOH analysis
were normal for his mother (red line) and his father (light blue line). The purple rectangle on the X chromosome indicates the hemizygous state
in the male samples. b Three allelic lines indicate the heterozygous state of the mother (red line) and father (light blue line), whereas the two
allelic lines indicate that an AOH occurred for a whole chromosome of the fetus (blue line). c-e A whole chromosome view clearly shows the
copy neutral AOH on chromosome 4 in the fetus (red arrow) and a normal chromosome 4 in his parents
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likely due to different homozygous recessive mutations
rather than aberrant imprinting. Spena et al. described
an iUPD4 case with a fibrinogenemia caused by a 15 kb
microdeletion [18]. Middleton et al. reported a complete
maternal iUPD4 case with a major predisposition to
mood disorders due to active recessive alleles [19]. Cot-
trell et al. reported that a homozygous recessive muta-
tion in the SGCB gene caused limb girdle muscular
dystrophy in a maternal UPD4 case [22], and Ding et al.
reported that a severe hypodysfibrinogenemia in a UPD4
case is also due to an homozygous mutation [21]. Re-
cently, Aminoff et al. described a maternal UPD4 case
with abetalipoproteinemia caused by a homozygous mu-
tation of the MTTP gene [36]; Losekot et al. described a
polycystic kidney disease in a maternal UPD4 case due
to a homozygous mutation in the PKD2 gene [23]. In
addition, there are other published papers that further
suggest that the clinical impact of UPD4 is caused by
homozygous mutations [37, 38]. Therefore, in our case,
we searched for homozygous autosomal recessive vari-
ants on chromosome 4 by WES.
In this study, 552 OMIM genes and 131 disease-
associated genes were identified in the iUPD4 region
involved; however, no pathogenic or likely pathogenic
variants were detected for those genes. After filtering
using Ingenuity software and bioinformatics analysis,
two rare frameshift and two nonsynonymous homozy-
gous variants for four non-disease related genes on
chromosome 4 were identified as variants of unknown
significance. Although these variants are predicted to
have a functional impact, none of these variants are
definitively associated with congenital abnormality or
Fig. 4 ChAS software directly indicates the origin of the isodisomic UPD. After comparing the genotyping results between the fetus and his
parents, ChAS software clearly indicated that the UPD of chromosome 4 in the fetus originated from the mother. At position chr4:3,418,266, the
genotyping was BB, AA and AB in the fetus, his father and his mother, respectively, which indicates that the B allele in the fetus was duplicated
from his mother. There are many different alleles that can be used to identify the origin of chromosome 4 in the fetus (red arrows)
Table 2 Summary of variants detected via WES
Type of Variants Total Variants Variants on Chromosome 4
Homozygous SNVs 20003 1343
Homozygous MNVs 20 3
Homozygous INDELs 1117 65
Heterozygous SNVs 27360 139a
Heterozygous MNVs 204 15a
Heterozygous INDELs 2531 61a
aAll heterozygosity variants with low quality are likely representative of
sequencing errors
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KIAA1211 57180473 Deletion c.805delC p.L269fsX13 Uncertain
Significance
MMRN1 90855967 SNV c.1136A > T p.K379I Damaging Possibly Damaging Uncertain
Significance
SLC25A31 128665845 SNV c.251G > A p.R84H Damaging Possibly Damaging Uncertain
Significance
NPY5R 164272419 Deletion c.997delG p.V333fsX7 Uncertain
Significance
Fig. 5 Rare variants identified via WES. a A homozygous variant was identified in the SLC25A31 gene (c.251G > A, p.R84H) via the NGS method.
b Sanger sequencing reference of SLC25A31. c The c.251G > A mutation (red arrow) was validated by Sanger sequencing
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inherited disease, and there are no literature reports
that these variants cause life-threatening malforma-
tions. Therefore, detailed ultrasound fetal morphology
and structural scanning was performed regularly in
this fetus; we did not find any structural abnormal-
ities, facial dysmorphisms or IUGR. In addition, the
couple was also informed that an imprinting effect as-
sociated with UPD4 could not be excluded because of
the limited understanding of imprinting in specific or-
ganisms [34, 35]. A healthy boy was born after the
couple was counseled with all of the prenatal diagnos-
tic results. At the last evaluation, the baby showed
normal development during his first year of birth.
To the best of our knowledge, this is the first prenatal
report of complete maternal iUPD of chromosome 4
without clinical findings utilizing the holistic approach
of ultrasound screening, CMA and WES testing. Al-
though no phenotypic abnormalities were observed in
this child after his first year of birth, further clinical
counseling and long term follow-up is necessary to rule
out the possibility of an intellectual disability and/or
mood disorder. It should be taken into account that
chromosome 4 has been weakly associated with mood
disorders [39], and some genes on chromosome 4, such
as RASGEF1B, MAPK10 and JNK3 [40, 41], are associ-
ated with intellectual disability.
In this study, the 1 in 58 high risk of Down syndrome
predicted by maternal serum screening was considered
as a false positive result by CMA. Whether the complete
UPD4 or other UPD event would influence the maternal
serum protein secreted and then influence the results of
maternal serum screening is unknown. It is interesting
to investigate the correlation between UPD events or
other comprehensive genetic variants and maternal
serum screening results.
In conclusion, due to the limited genetic information
and complex effect of UPD and imprinting, prenatal
diagnosis of a rare UPD event is complicated. The
iUPD4 case that we studied might be benign and com-
pletely unrelated to a clinical phenotype. In any event,
by combining CMA, WES and ultrasound technology,
we were able to provide comprehensive genetic and fetal




The Ethics Committee of the Third Affiliated Hospital of
the Guangzhou Medical University approved this re-
search. Written informed consent was obtained from the
couple prior to performing the invasive prenatal
diagnosis.
In this study, a 28-year-old gravida 1 para 0 woman was
referred to the hospital for a genetic consultation at
20 weeks of gestation because maternal serum screening
revealed a 1 in 58 risk for Down syndrome. Her husband
was 30 years old. The couple declared that they were non-
consanguineous and had no family history of congenital
anomalies. An amniotic fluid sample (15 ml) was obtained
for karyotyping and CMA testing, and peripheral blood
samples from the parents were collected. A fetal cord
Fig. 6 Detailed screening by ultrasound. No facial cleft or other structural abnormalities were observed in this fetus. Detailed ultrasound screening at
25 weeks of gestation show (a) a normal lateral ventricle view; (b) nasal bone view; (c) palate and lip view; and (d) apical four chamber heart view
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blood sample was collected at 25 weeks of gestation for
further validation.
Karyotype analysis
For chromosome analysis, 20 metaphase cells from am-
niotic fluid sample were examined using the G-banding
method in situ from two independent cultures and the
400-banding level of chromosome was achieved.
DNA extraction
Genomic DNA was extracted and purified from uncul-
tured amniocytes, peripheral blood samples and a fetal
cord blood sample using a QiagenDNeasy Tissue Kit ac-
cording to the manufacturer’s instructions (Qiagen, Hil-
den, Germany).
SNP-based CMA analysis and data interpretation
High-quality genomic DNA (250 ng) was digested, li-
gated, PCR amplified, labeled and hybridized to CytoS-
can 750 K arrays according to the manufacturer's
protocol (Affymetrix, Santa Clara, CA, USA). After be-
ing washed and stained, the microarrays were scanned
using an Affymetrix 7G scanner. The data were analyzed
usingAffymetrix Chromosome Analysis Suite (ChAS 2.2,
Affymetrix, Santa Clara, CA, USA). Next, 50 probes, a
loss-size of 50 kb, a gain-size of 100 kb, and a 5,000 kb
UPD region were designated as the analysis thresholds.
The locations of the copy number variations (CNVs) and
the UPD events were determined based on a human
genome assembly from February 2009 (GRCH37/h19).
For data interpretation, the Database of Genomic Vari-
ants (DGV), the Database of Chromosome Imbalance
and Phenotype in Humans Using Ensemble Resources
(DECIPHER), the Clinical Genome Resource (ClinGen),
OMIM genes and our lab's in-house database were used
to evaluate the CNVs identified in this study. Evaluation
of UPD events was performed using the Genomic Oli-
goarray and SNP array evaluation tool [42] following the
guidelines of the Canadian College of Medical Geneti-
cists (CCMG) [43].
Whole exome sequencing
WES was performed to investigate single nucleotide
variants (SNVs) or small insertion/deletions (InDels)
in the fetal cord blood. High-quality genomic DNA
(100 ng) was amplified in Ion AmpliSeq Exome RDY
plates using Ion AmpliSeq HiFi Mix (Ion Torrent,
Carlsbad, CA). The resulting 240–280 bp amplicons
were treated with FuPa Reagent (Ion Torrent) to
partially digest the primers and phosphorylate the
amplicons, which were then ligated to Proton
adapters and purified according to the manufactur-
er's instructions (Ion Torrent). Libraries were quanti-
fied by quantitative PCR and then loaded onto the
Ion Proton platform for high-throughput sequencing.
The raw sequencing output data of the Ion sequen-
cer were processed using the Torrent sequence gen-
eration algorithm. The standard bioinformatics
analysis begins with the raw data generated from the
Ion Proton sequencing pipeline. Firstly, TMAP
(https://github.com/nh13/TMAP) was used to align
reads to the reference sequence. The alignment in-
formation was stored in BAM format files. After
alignment, the final BAM files were ready for variant
calling. SNPs and InDels were all detected using the
Torrent Variant Caller (https://github.com/iontor-
rent/Torrent-Variant-Caller-stable) (TVC) and anno-
tated using Ion Reporter software (IR). Quality
control (QC) was required at each stage of the ana-
lysis pipeline for the raw data, the alignment and the
called variant. The data were aligned and mapped to
the NCBI reference genome (GRCH37/h19) and were
further analyzed and filtered using NextGene soft-
ware (SoftGenetics, LLC, PA, USA), the wANNO-
VAR web server (http://wannovar.usc.edu/) and
Ingenuity software (http://www.ingenuity.com/).
Confirmation of identified variants
WES data were validated by comparison of the SNP in-
formation derived from the CMA. Sanger sequencing
was used to confirm rare variations identified by WES
that were not covered by the probes of the CMA.
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Additional file 1: Table S1. Timeframe of gestational weeks for
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